DOPRAM Drug Patent Profile
✉ Email this page to a colleague
When do Dopram patents expire, and when can generic versions of Dopram launch?
Dopram is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in DOPRAM is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dopram
A generic version of DOPRAM was approved as doxapram hydrochloride by CHARTWELL INJECTABLE on January 10th, 2003.
Summary for DOPRAM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 230 |
Clinical Trials: | 3 |
Patent Applications: | 1,257 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DOPRAM |
What excipients (inactive ingredients) are in DOPRAM? | DOPRAM excipients list |
DailyMed Link: | DOPRAM at DailyMed |
Recent Clinical Trials for DOPRAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universitaire Ziekenhuizen Leuven | Phase 3 |
Nederlands Neonataal Netwerk (N3), the Netherlands | Phase 3 |
Erasmus Medical Center | Phase 3 |
Pharmacology for DOPRAM
Drug Class | Respiratory Stimulant |
Physiological Effect | Increased Medullary Respiratory Drive |
Anatomical Therapeutic Chemical (ATC) Classes for DOPRAM
US Patents and Regulatory Information for DOPRAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | DOPRAM | doxapram hydrochloride | INJECTABLE;INJECTION | 014879-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |